WO2010018692A1 - Dispositif ultrasonographique - Google Patents

Dispositif ultrasonographique Download PDF

Info

Publication number
WO2010018692A1
WO2010018692A1 PCT/JP2009/052767 JP2009052767W WO2010018692A1 WO 2010018692 A1 WO2010018692 A1 WO 2010018692A1 JP 2009052767 W JP2009052767 W JP 2009052767W WO 2010018692 A1 WO2010018692 A1 WO 2010018692A1
Authority
WO
WIPO (PCT)
Prior art keywords
contrast agent
transmission
echo signal
ultrasonic diagnostic
image data
Prior art date
Application number
PCT/JP2009/052767
Other languages
English (en)
Japanese (ja)
Inventor
玲衣 浅見
健一 川畑
隆 東
Original Assignee
株式会社日立製作所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社日立製作所 filed Critical 株式会社日立製作所
Priority to JP2010524675A priority Critical patent/JP5159885B2/ja
Publication of WO2010018692A1 publication Critical patent/WO2010018692A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48—Diagnostic techniques
    • A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/13—Tomography
    • A61B8/14—Echo-tomography

Definitions

  • the present invention relates to an ultrasonic diagnostic apparatus, and more particularly to an ultrasonic diagnostic apparatus that can depict a finer disease site by presenting the distribution of an ultrasonic contrast agent present in a diagnostic site of a subject administered with an ultrasonic contrast agent.
  • the present invention relates to an ultrasonic diagnostic apparatus.
  • ultrasonic diagnostic equipment has low impact on the human body, high safety, high portability, short imaging time, real-time imaging is possible, small size, low cost, high introduction rate even in clinics, etc. It is an indispensable tool for diagnosis of fetus in obstetrics and gynecology, diagnosis of abdomen, mammary gland, urinary organs, heart disease, etc.
  • a pulse echo type that obtains two-dimensional image data with a simple operation by simply bringing a probe into contact with the body surface is the mainstream.
  • An acoustic pulse transmitted from the surface of the body in contact with the probe to the inside of the body is reflected at a site having a different acoustic impedance such as a tissue and a cell in the body.
  • the reflected echo is received by the ultrasonic transducer, and the time taken for reflection is processed in the depth direction, and the reflection intensity is processed as luminance.
  • a two-dimensional luminance image is obtained.
  • the ultrasonic contrast agent used at this time is generally a microbubble having a size of about 1-5 microns stabilized by a surfactant, a polymer or the like.
  • the microbubble contrast agent reflects an ultrasonic signal due to a difference in acoustic impedance at the gas-liquid interface, and is particularly suitable for imaging a capillary blood vessel.
  • contrast echo such as flash echo (such as Non-Patent Document 1) that captures the reperfusion of the contrast agent after the bubble is intentionally collapsed.
  • a typical example is a harmonic imaging method (for example, Patent Document 1) that resonates and images a characteristic acoustic response.
  • the ultrasonic imaging method using a microbubble contrast agent has a drawback that microbubbles stay in blood vessels and do not penetrate into the tissue, so that the tissue itself cannot be imaged. Therefore, as a new ultrasonic contrast agent, as disclosed in Patent Document 2 and Non-Patent Document 2, the size of the contrast agent is set to a submicron size, aiming at leakage from new blood vessels and the like, aiming at contrasting deeper tissues. Development of new contrast methods has been carried out.
  • the bubble contrast agent has been reported in Patent Document 2, an ultrasound imaging system approved for diagnosis, and a can contrast in ultrasound imaging intensity defined by M echanical I ndex (MI) value Therefore, early commercialization is expected.
  • MI M echanical I ndex
  • an aerated contrast agent encapsulates a low-boiling poorly water-soluble liquid in an overheated state in advance, and eliminates overheating with ultrasonic energy at the target site to restore the original boiling point of the liquid.
  • It is a type of contrast agent that is vaporized into bubbles and has two features. First, by setting the diameter of the particles to 0.5 microns or less, it is possible to achieve a tissue other than blood vessels, which is difficult with a conventional microbubble contrast agent. Second, it is possible to localize the microbubbles by irradiating only the target site with ultrasonic waves.
  • tissue ultrasound imaging is performed using an aerated contrast agent
  • ultrasound with a certain negative pressure is required to cause a phase change from a droplet to a bubble using the sound pressure of the ultrasound.
  • an ultrasonic probe provided in a general ultrasonic diagnostic apparatus scans a transmission beam converged at a focal point to obtain a tissue tomographic image.
  • Bubbles are generated only at the focal part where the sound pressure is locally increased (not visible as a contrast agent).
  • the present invention visualizes all the aerated contrast medium present in the tissue tomographic screen while maintaining the real-time property, and reliably distinguishes and generates only the contrast medium-derived signal generated thereby. It aims at providing the technique to do.
  • the ultrasonic diagnostic apparatus of the present invention uses a probe configured of a plurality of ultrasonic irradiation sources from the body surface of a subject to which an ultrasonic contrast agent is administered.
  • a transmission beam is formed by temporally controlling the voltage applied to the source and a tissue tomogram is formed using the received echo signal corresponding to this transmission beam, each ultrasonic irradiation source
  • Different transmission beams with different focal lengths obtained by changing the temporal control of the applied voltage are irradiated in time series so that the transmission beams with longer focal lengths come first.
  • a reference received echo signal beam profile is determined from each received echo signal obtained corresponding to each transmitted beam having a predetermined beam profile, and all received echo signals have the reference beam profile.
  • the focal length and the interval between the adjacent focal lengths should be defined by the concentration of the locally existing contrast agent, the characteristics of the transmission beam, and the region of interest.
  • concentration of the contrast agent it is possible to define a certain range by assuming a dose safe for a predetermined living body.
  • the present invention includes a processing unit that calculates a focal length condition that can be influenced by characteristics such as a focal length, an applied voltage, and a frequency of a transmission beam.
  • the focal distance and the contrast range are variable, and individual differences of the subject such as the contrast agent concentration and the region of interest can be reflected.
  • bubbles are widely used as an ultrasound contrast agent because they have the property of reflecting ultrasound, and therefore have the property of shielding ultrasound when present at high concentrations.
  • the transmission beam having the longest focal length is irradiated first, and the focal length is shortened in order.
  • At least one signal among a plurality of reception echo signals by a plurality of transmission beams has an imaging field of view necessary for acquiring a tissue tomographic image, and only reception echo signals around the focal point are acquired in other transmission beams. It has the characteristic of doing. This means that the pulse repetition frequency (PRF) is kept high, and the reduction in the imaging frame rate caused by irradiating multiple beams to the same part of the subject is minimized, and real-time characteristics can be maintained. To do.
  • PRF pulse repetition frequency
  • this invention has the calculating part which irradiates the same site
  • the ultrasonic diagnostic apparatus receives the received echo signal immediately before except for the first received echo signal among the received echo signals obtained by a plurality of transmission beams having different focal lengths irradiated on the same part of the subject.
  • a calculation unit for converting into a received echo signal assuming the same focal length as the echo signal, and a storage unit storing numerical values necessary for the conversion process.
  • the differential process and the conversion calculation process associated therewith may be limited to only the vicinity of the focal distance where bubble formation may occur in the received echo signal. Furthermore, the individual difference information obtained by the above calculation processing has contrast agent information at each focal point, and by integrating this, the distribution information of the contrast agent in the region of interest in the tomogram is obtained. Can be presented.
  • the tissue tomographic image data obtained by sequentially mapping the received echo signals to the depth necessary for obtaining the tissue tomographic image in the azimuth direction, and the contrast agent distribution image data calculated from the contrast agent distribution information are independently obtained.
  • the contrast agent distribution image data can be displayed in different colors or intensities depending on the contrast agent concentration or the amount that can be converted into the concentration.
  • concentration information of multiple frames obtained by multiple times of imaging by the above method is integrated and displayed on a single screen display. It is also possible to do.
  • the present invention all of the aerated contrast agent existing in the tissue tomographic screen of the subject is visualized, and only the contrast agent-derived signal generated thereby is reliably distinguished and displayed superimposed on the tissue tomographic image. This makes it possible to grasp more detailed contrast medium distribution information. For this reason, more detailed information on the state of the lesion can be provided, small lesions and numerous lesions can be easily detected, and early diagnosis of lesions and accurate and safe treatment can be assisted.
  • FIG. 1 is a block diagram showing an embodiment of an ultrasonic diagnostic apparatus according to the present invention.
  • FIG. 1 is a block diagram showing an embodiment of an ultrasonic diagnostic apparatus according to the present invention.
  • This ultrasonic diagnostic apparatus uses a pulsed ultrasonic wave to obtain and display a tomographic image of a diagnostic region of a subject to which a contrast medium has been administered in advance.
  • a probe 1 and an input unit 3 are displayed on a diagnostic machine main body 2.
  • the display unit 4 is connected.
  • the diagnostic machine body 2 includes a transmission / reception sequence control unit 7, a reception beamformer 5, a transmission beamformer 6, a transmission delay / weight selection unit 16, a changeover switch 15, a wave reception processing unit 13, a tissue tomogram calculation unit 10, and a difference calculation unit. 14, a correction calculation unit 8, a correction calculation memory 9, an integration processing unit 11, and a display data synthesis unit 12.
  • the probe 1 is a device responsible for transmission / reception of ultrasonic signals to / from the subject.
  • any probe may be used as long as it can converge the beam and can transmit and receive ultrasonic waves that satisfy the conditions necessary for bubbling.
  • the input unit 3 is a console necessary for giving various instructions to the diagnostic machine body 2. A region of interest, a focal length change, and an ultrasonic transmission condition can be changed by inputting to the console. Furthermore, the display method on the display unit 3 can be switched, for example, a two-screen display of a tissue tomogram and contrast agent distribution information or a superimposed display.
  • the transmission beam is transmitted to the subject via the probe 1 under conditions such as an appropriately applied voltage.
  • the transmission beam transmission conditions are defined by the transmission / reception sequence control unit 7 as described later.
  • the transmission / reception sequence controller 7 is one of the constituent elements that characterize the present invention.
  • the reception echo signal received by the probe 1 from the inside of the subject becomes a reception echo signal to which reception directivity is given by the reception beamformer 5 in the diagnostic machine main body 2.
  • the reception beamformer 5 has a reception delay circuit (not shown), and forms a reception delay circuit according to a time range for acquiring reception echo signals by respective transmission beams defined by the transmission / reception sequence control unit 7.
  • the reception processing unit 13 in the diagnostic machine main body 2 detects the reception echo signal obtained by the reception beamformer 5.
  • the reception echo signal may exist n times as many as the scanning lines required in the azimuth direction.
  • These received echo signals are finally sent to the display data synthesizing unit 12 through the tissue tomographic image calculation unit 10, the difference calculation unit 14, the correction calculation unit 8, and the integration processing unit 11, and are provided as image data. It is.
  • the tissue tomogram calculation unit 10 uses only a reception echo signal having the longest imaging field of view among a plurality of reception echo signals transmitted by the transmission beam transmitted to the same part, and uses a raster signal sequence in the ultrasonic scanning direction as a video format. To the display data composition unit 12.
  • the correction calculation unit 8 determines a reference beam profile for a plurality of reception echo signals obtained by transmission beams having different beam profiles because the focal lengths are different, and transmits all reception echo signals having the reference beam profile.
  • the received echo signal intensity at each point is corrected and calculated so that the received echo signal is substantially equivalent to that obtained by the beam. Furthermore, it has the memory 9 which stored the numerical value required for the said conversion process.
  • the correction calculation unit 8 and the correction calculation memory 9 that perform the correction process are one of the constituent elements that characterize the present invention.
  • the difference calculation unit 14 calculates the difference between the received echo signals corrected by the correction calculation unit 8.
  • the integration processing unit 11 irradiates the same part of the subject and stores individual differential echo signals obtained by the arithmetic processing, and performs integration processing, and integrates the differential echo signals at the respective focal points. By doing so, contrast agent distribution information is generated. Further, the contrast agent distribution information is changed from the raster signal sequence in the ultrasonic scanning direction to the raster signal sequence in the video format, and this is sent to the display data synthesis unit 12.
  • the display data synthesizing unit 12 synthesizes the tissue tomographic image data and the contrast agent part image data as image data based on the display method specified by the input unit 3 and sends it to the display unit 4 together with desired setting parameters.
  • the display unit 4 displays these data on a screen such as a cathode ray tube or a liquid crystal.
  • FIG. 2 is a conceptual diagram showing an example of an irradiation method of a plurality of transmission beams for forming one raster according to the present invention.
  • One arrow in the figure represents one transmission beam S (n), and a dotted line R illustrated on the right side of each arrow represents a time range in which a reception echo signal by each transmission beam is acquired.
  • At least three transmission beams are irradiated to the same part.
  • the focus of the transmit beam S (n) is F (m).
  • the transmission beam with the longest focal length is irradiated first, and the focal length of the transmission beam is shortened in order.
  • the distance between F (m) and F (m + 1) needs to be equal to the range in the depth direction that is bubbled by one transmission beam, as will be described later. Is calculated.
  • FIG. 3 is a conceptual diagram showing another example of the irradiation method of a plurality of transmission beams for forming one raster in the present invention.
  • the focus of the transmit beams S (2n) and S (2n-1) is F (m). That is, S (2n) and S (2n-1) have the same focal length, the transmission beam having the longest focal length is irradiated first, and the focal length of the beam is shortened in order for every two transmission beams. .
  • the calculation method of the distance between F (m) and F (m + 1) and the end point of the acquisition time range of the received echo signal R is the same as the irradiation method shown in FIG.
  • This irradiation method takes about twice as long as the imaging time as compared with the irradiation method shown in FIG. 2, but has the advantage of simplifying the structure because the correction calculation as shown in FIG. 5 is not required.
  • the control of this irradiation method is specified in the transmission / reception sequence control unit 7.
  • FIG. 4 schematically shows an example of a method for calculating the focal length interval.
  • the ultrasound irradiation condition sufficient for bubbling is defined as the condition where bubbling can be obtained with half the sound pressure obtained at the focal point.
  • the range in the depth direction where bubble formation occurs is a range F ⁇ (a / 2) centered on the focal point.
  • the focal point F (x) it is also possible to perform correction in consideration of attenuation in the living body (0.5 dB / MHz / cm in normal liver tissue) according to the focal point F (x). For example, when correction by attenuation is performed, the range a (2)> a (1). It is also possible to change the focal interval, reflecting the local concentration of the contrast agent, which is represented by ⁇ a in FIG. For example, in the liver or the like, it is conceivable that the local concentration increases due to the uptake of the contrast agent by Kupffer cells. That is, it is expected that bubble formation will occur at a sound pressure lower than the ultrasonic conditions required for bubble formation assuming other normal tissue concentrations, and bubble formation will occur in a wider range than a.
  • the range where bubble formation occurs is represented by a + ⁇ a ( ⁇ a> 0).
  • ⁇ a is set based on the sound pressure condition necessary for bubbling required at a high concentration.
  • the pulse repetition frequency has the same meaning as the reciprocal of the time range in which the received echo signal R (n) represented by the dotted line in FIGS. 2 and 3 is acquired. The longer the dotted line, the lower the frequency.
  • the pulse repetition frequency is increased, so that the time required for imaging can be shortened. This is controlled by the reception beamformer 6 and the transmission / reception sequence controller 7.
  • the number of transmission pulses that irradiate the same part is basically calculated based on the range of the tissue tomogram and the distance between F (m) and F (m + 1). You can also do it. This is particularly effective when a region to which a contrast medium will be present in the tissue tomogram is predicted in advance. In particular, in imaging where real-time characteristics are important, by defining the region of interest, not only the number of transmission pulses that irradiate the same part, but also the number of scanning lines required in the azimuth direction can be reduced, and the frame rate can be improved. There is also an effect that leads to.
  • transmission beams S are transmitted to the subject via the probe 1, and the received echo signal R reflected and returned also passes through the probe 1 via the reception beam former 6 and the reception processing unit 13. It is sent to the difference calculation unit 14.
  • the absolute value of the difference between the two received echo signals R obtained most recently by irradiating the same part of the subject is calculated.
  • This calculation is the absolute value of ⁇ R (n) ⁇ R (n ⁇ 1) ⁇ in the example of FIG. 2, where n ⁇ 1, and in the example of FIG. 3, ⁇ R (2n) ⁇ R (2n ⁇ 1) ⁇ It is expressed as an absolute value.
  • a difference calculation is performed after a correction calculation described below is performed in advance.
  • the time interval between the two most recent pulses is on the order of several kHz, and the movement is at least three orders of magnitude faster than the component derived from the body movement of the subject. Therefore, by this difference processing, it is possible to extract only the contrast agent component and display the detailed contrast agent distribution.
  • FIG. 5 is a conceptual diagram showing correction processing for difference calculation according to the present invention.
  • the ultrasonic transmission beam is focused in the subject and is narrowed to the narrowest range at the focal point F.
  • the sound pressure on the beam center axis increases in inverse proportion to the beam width, and reaches the maximum sound pressure at the focal point F.
  • This is the relative sound pressure on the central axis normalized by the sound pressure at the front face of the transducer built in the probe 1, Z the distance from the probe normalized by the focal length, and D the sound
  • a parameter representing the degree of focus it can be expressed as the following equation.
  • the ultrasonic diagnostic apparatus has sound pressure distribution data of ultrasonic beams having different focal points in the correction calculation memory unit 9 within a range of parameters that can be assumed based on this formula and tuning at the time of mounting. .
  • the change ⁇ I S of the sound pressure value of the transmission beam S (n) for each correction calculation slot ⁇ z that is, the distance from the sound source (probe)
  • the signal intensity distribution value [Delta] R of the received echo signals assuming a uniform sound field.
  • the correction calculation process is performed on a plurality of received echo signals assuming different ⁇ I S / ⁇ z, that is, different ⁇ I R / ⁇ z, so that the plurality of received echo signals become substantially equivalent echo signals.
  • the received echo signal intensity for each ⁇ z is corrected.
  • FIG. 6 shows a schematic diagram of a specific example of the correction calculation.
  • the horizontal axis represents one correction calculation slot.
  • the received echo signals R (1) and R (2) obtained by the transmission beams S (1) and S (2) having different beam profiles are actually in the tissue. It is considered to exhibit a response, such as in the range from shaded portion dZ 1 of dZ 2 due to the influence of various scatterers.
  • ⁇ I R2 By correcting ⁇ I R2 using the correction coefficient ( ⁇ I R1 / ⁇ I R2 ) from the value stored in the memory unit 9, it is possible to perform correction processing even in a region affected by such a nonlinear scatterer.
  • FIG. 7 shows a simplified schematic diagram of a received echo signal in a state where a contrast agent is actually present as another specific example of the correction calculation. In the range from dZ 1 to dZ 2, the signal R (1) including the contrast agent component is corrected to R (2), and the absolute value of the difference is generated.
  • the difference processing and the correction processing associated therewith are limited to the range of F ⁇ (a / 2 + ⁇ a) shown in FIG. 4, that is, only around the focal point where the bubble formation of the received echo signal can occur. You may do it.
  • the difference processing is dynamically performed every time two received echo signals are accumulated, but the difference echo signal is temporarily stored in the integration processing unit 11.
  • the difference echo signal is temporarily stored in the integration processing unit 11.
  • the display data synthesizing unit 12 synthesizes the tissue tomographic image data and the contrast agent distribution image data as image data based on the display method specified by the input unit 3 and sends the image data to the display unit 4 together with desired setting parameters.
  • the tissue tomographic image data can be displayed as a gray scale image
  • the contrast agent distribution image data can be displayed as different color scale images. It is also possible to display the tomographic image of the contrast agent, which is a transient signal component, at the same time for diagnosis. Further, the contrast medium distribution image data can be displayed in a color map by changing the color or intensity in accordance with the contrast medium concentration or the amount that can be converted into the density.
  • the contrast distribution information over multiple imaging times can be integrated and displayed on a single screen display, and it is also possible to present lesion information more clearly when contrast medium is present only at low concentrations. It is.
  • the tissue tomographic image data to be superimposed is that of the first frame, and only the contrast agent information image data is integrated in the frame direction. For example, when the data density obtained by this method is imaged at a frame rate of 30, if one second of data is accumulated and displayed, it is possible to simply obtain contrast agent information data having a density 30 times higher.
  • FIG. 8 shows an example of the quantitativeness of contrast agent concentration information obtained by the present invention. This is because an aerated contrast agent having a known concentration within a range that does not affect the health of the subject is enclosed in an acrylamide gel, and all the aerated contrast agents present in the gel are based on the irradiation sequence according to the present invention. After irradiating the ultrasonic wave with the intensity that can be bubbled, the received echo signal from the region of interest is analyzed, and finally the integrated value of the differential echo signal is graphed. From the graph, it can be said that the aerated contrast agent concentration and the integrated value of the differential echo signal generated thereby have a linear relationship. That is, it can be said that the differential echo signal integrated value corresponds to relative contrast agent concentration information.
  • a reception echo signal (illustrated image obtained by imaging the first reception echo signal) by transmission beams having different focal lengths has both a tissue-derived signal and a contrast agent-derived signal at the focal point.
  • a contrast agent-derived signal at the focal point is extracted (the figure shows four different focal points). Assumed to have).
  • contrast agent distribution information is formed.
  • the display data synthesis unit 12 superimposes it on the tissue tomographic image and displays it on the display unit 4 by changing the color tone. It can be presented in detail.
  • FIG. 10 shows an example of the effect when the contrast agent distribution information over a plurality of imaging times is integrated and displayed on a single screen display. This is because the contour of the affected area is not clear in the first frame from which accumulation starts, since only a low concentration of contrast medium distribution is obtained. However, as the frame accumulation is repeated, the contrast medium concentration is virtually increased. This is an example where the outline gradually becomes clear.
  • the present invention is not limited to the above-described embodiment as it is, and can be embodied by modifying constituent elements without departing from the scope of the invention in the implementation stage.
  • an invention formed by an appropriate combination of a plurality of constituent elements disclosed in the above embodiment is also included in the scope of the present invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

Il est possible de visualiser l'ensemble d'une bouillie barytée avec bulle existant dans une tomographie des tissus en temps réel, et de distinguer de manière sûre les signaux provenant de ladite bouillie barytée de manière à obtenir une image. Un faisceau de transmission est appliqué, à partir d'une sonde (1), à une personne examinée à laquelle la bouillie barytée ultrasonographique a été administrée. Lorsqu'une tomographie des tissus est obtenue au moyen d'un écho accompagnant la transmission, une pluralité de faisceaux de transmission présentant différentes distances focales est appliquée dans l'ordre décroissant de la distance focale, et le signal d'écho de réception accompagnant l'application du faisceau est soumis à un calcul de correction. Une unité de calcul de différence (14) calcule une différence entre un faisceau de réception et un faisceau de réception immédiatement avant. Une unité de traitement de multiplication (11) réalise une multiplication, de manière à permettre la visualisation de l'ensemble de la bouillie barytée avec bulle, et extrait uniquement le composant de bouillie barytée pour permettre l'obtention d'une image.
PCT/JP2009/052767 2008-08-12 2009-02-18 Dispositif ultrasonographique WO2010018692A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010524675A JP5159885B2 (ja) 2008-08-12 2009-02-18 超音波診断装置

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008207599 2008-08-12
JP2008-207599 2008-08-12

Publications (1)

Publication Number Publication Date
WO2010018692A1 true WO2010018692A1 (fr) 2010-02-18

Family

ID=41668839

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/052767 WO2010018692A1 (fr) 2008-08-12 2009-02-18 Dispositif ultrasonographique

Country Status (2)

Country Link
JP (1) JP5159885B2 (fr)
WO (1) WO2010018692A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013146696A1 (fr) * 2012-03-26 2013-10-03 国立大学法人 富山大学 Dispositif de surveillance d'injection intravasculaire et système de surveillance d'injection intravasculaire l'utilisant

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006043359A1 (fr) * 2004-10-22 2006-04-27 Hitachi Medical Corporation Milieu de contraste ultrasonore
JP2006320405A (ja) * 2005-05-17 2006-11-30 Hitachi Ltd 超音波診断治療装置
JP2008206724A (ja) * 2007-02-27 2008-09-11 Hitachi Ltd 超音波撮像装置
JP2008272367A (ja) * 2007-05-07 2008-11-13 Hitachi Ltd 超音波撮像システム

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006043359A1 (fr) * 2004-10-22 2006-04-27 Hitachi Medical Corporation Milieu de contraste ultrasonore
JP2006320405A (ja) * 2005-05-17 2006-11-30 Hitachi Ltd 超音波診断治療装置
JP2008206724A (ja) * 2007-02-27 2008-09-11 Hitachi Ltd 超音波撮像装置
JP2008272367A (ja) * 2007-05-07 2008-11-13 Hitachi Ltd 超音波撮像システム

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KEN'ICHI KAWABATA ET AL.: "Shindan · Chiryoyo Sohenkagata Cho Onpa Zoeizai ni Kansuru Kento", JOURNAL OF MEDICAL ULTRASONICS, vol. 35, 15 April 2005 (2005-04-15), pages S246 *
KEN'ICHI KAWABATA ET AL.: "Usagi Kanzo Gan Model o Mochiiru Sohenka Nano Zoeizai no Seitai Koka Kensho", JOURNAL OF MEDICAL ULTRASONICS, vol. 35, 15 April 2008 (2008-04-15), pages S287 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013146696A1 (fr) * 2012-03-26 2013-10-03 国立大学法人 富山大学 Dispositif de surveillance d'injection intravasculaire et système de surveillance d'injection intravasculaire l'utilisant

Also Published As

Publication number Publication date
JP5159885B2 (ja) 2013-03-13
JPWO2010018692A1 (ja) 2012-01-26

Similar Documents

Publication Publication Date Title
JP3580627B2 (ja) 超音波診断装置
JP5376877B2 (ja) 超音波診断装置および画像表示プログラム
JP5868067B2 (ja) 医用画像診断装置、画像処理装置及び方法
KR100932472B1 (ko) 병변조직을 검출하는 초음파 진단 시스템
WO2014077396A1 (fr) Dispositif d'échographie et procédé de traitement d'image
WO2014065338A1 (fr) Dispositif de diagnostic ultrasonore et procédé de commande de dispositif de diagnostic ultrasonore
US9138202B2 (en) Ultrasonic diagnosis apparatus and medical image processing method
US20110245675A1 (en) Ultrasonic diagnostic apparatus, ultrasonic image processing apparatus, and medical diagnostic imaging apparatus
US20110270087A1 (en) Method and apparatus for ultrasonic diagnosis
US7588538B2 (en) Ultrasonic diagnostic equipment and image processing apparatus
JP2001061841A (ja) 超音波診断装置及び超音波画像の生成方法
JP2019188005A (ja) 超音波診断装置及び穿刺支援プログラム
JPH1033535A (ja) 超音波ドプラ診断装置および超音波ドプラ診断の方法
JPH11327A (ja) 超音波診断装置
US6607490B2 (en) Ultrasonic diagnostic apparatus and control method thereof
JPH0227631B2 (fr)
JP2003260056A (ja) 超音波診断装置
JP2007195867A (ja) 超音波診断装置及び超音波画像表示プログラム
JP5121384B2 (ja) 超音波診断装置
JP5159885B2 (ja) 超音波診断装置
Yoshikawa et al. Dynamic and precise visualization of contrast agent in blood vessels with motion correction
JP2012245092A (ja) 超音波診断装置
JP2002028160A (ja) 超音波診断装置
CN115708933A (zh) 基于超声成像的聚焦超声治疗系统
JP5322767B2 (ja) 超音波診断装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09806588

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010524675

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09806588

Country of ref document: EP

Kind code of ref document: A1